These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17908180)

  • 21. Prognostic significance of the standardized uptake value of pre-therapeutic (18)F-FDG PET in patients with malignant lymphoma.
    Ahmadzadehfar H; Rodrigues M; Zakavi R; Knoll P; Mirzaei S
    Med Oncol; 2011 Dec; 28(4):1570-6. PubMed ID: 20524086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphoma.
    Mikosch P; Gallowitsch HJ; Zinke-Cerwenka W; Heinisch M; Pipam W; Eibl M; Kresnik E; Unterweger O; Linkesch W; Lind P
    Acta Med Austriaca; 2003; 30(2):41-7. PubMed ID: 12752087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in a patient with human immunodeficiency virus-associated Castleman's disease and Kaposi sarcoma, disorders associated with human herpes virus 8 infection.
    Bertagna F; Biasiotto G; Rodella R; Giubbini R; Alavi A
    Jpn J Radiol; 2010 Apr; 28(3):231-4. PubMed ID: 20437136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evolution in 18F-FDG-PET of a case of Hodgkin disease, nodular sclerosis variety, after treatment and autotrasplant].
    Sánchez-Salmón A; Barandela J; Garrido M; Ciobotaru AB; Albo C; Ruibal A
    Rev Esp Med Nucl; 2007; 26(3):165-8. PubMed ID: 17524311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma.
    Crocchiolo R; Fallanca F; Giovacchini G; Ferreri AJ; Assanelli A; Verona C; Pescarollo A; Bregni M; Ponzoni M; Gianolli L; Fazio F; Ciceri F
    Ann Hematol; 2009 Dec; 88(12):1229-36. PubMed ID: 19468730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease).
    Abdel-Reheim FA; Koss W; Rappaport ES; Arber DA
    Arch Pathol Lab Med; 1996 Jan; 120(1):91-6. PubMed ID: 8554455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients].
    Oriuchi N; Higuchi T; Endo K; Tsukamoto N; Matsuda H; Kuji I; Murakami K; Nakajima K
    Kaku Igaku; 2009 Jun; 46(2):96-9. PubMed ID: 19637820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
    Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation.
    Iagaru A; Mari C; Sam Gambhir S
    Rev Esp Med Nucl; 2007; 26(1):40-5. PubMed ID: 17286947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma.
    Torizuka T; Nakamura F; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Kobayashi M; Ouchi Y
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):22-8. PubMed ID: 14574514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET?
    Reinhardt MJ; Herkel C; Altehoefer C; Finke J; Moser E
    Ann Oncol; 2005 Sep; 16(9):1524-9. PubMed ID: 15946979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential application of chemotherapy and monoclonal CD 20 antibody: successful treatment of advanced composite-lymphoma.
    Linck D; Lentini G; Tiemann M; Fauser AA; Parwaresch R; Basara N
    Leuk Lymphoma; 2005 Feb; 46(2):285-8. PubMed ID: 15621815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report.
    Pirozzi A; Cartenì G; Scagliarini S; Fusco M; Riccardi F
    Medicine (Baltimore); 2019 Mar; 98(11):e14805. PubMed ID: 30882658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follicular dendritic cell hyperplasia in plasma cell variant of Castleman's disease with interfollicular Hodgkin's disease.
    Vasudev Rao T; Alkindi S; Pathare AV
    Pathol Res Pract; 2007; 203(6):479-84. PubMed ID: 17418501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L; Chen Y; Wu J
    Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
    Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.
    Lyapichev KA; You MJ; Vega F; Solis LM; Medeiros LJ
    Virchows Arch; 2020 Sep; 477(3):437-444. PubMed ID: 32152665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG avid in uterine leiomyoma: a case report.
    Chiewvit S
    J Med Assoc Thai; 2012 Feb; 95(2):288-92. PubMed ID: 22435263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.